CARsgen Therapeutics Announces NDA Acceptance of Satri-cel by China's NMPA ...Middle East

SHANGHAI, June 25, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the National Medical Products Administration (NMPA) of China has accepted the New Drug Application (NDA) for...

Hence then, the article about carsgen therapeutics announces nda acceptance of satri cel by china s nmpa was published today ( Thursday 26/06/2025 - 03:16 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CARsgen Therapeutics Announces NDA Acceptance of Satri-cel by China's NMPA )

Also on site :

• Hollywood mourns loss of beloved makeup artist Jasen Kaplan
• Suspected mountain lion attack in Colorado mountains under investigation
• Person falls to death on Boylston Street on New Year’s Eve